CCR Monthly Approval Report – March 2017

Here is a rundown of the financial instruments approved, rejected and affirmed by Chile’s Comisión Clasificadora de Riesgo (CCR). Month of March 2017.

Fifteen mutual funds and six ETFs were added in March to the list of approved instruments eligible to receive allocations from Chilean Pension Managers (AFPs). Of those, 13 are domiciled in Luxembourg, six in USA, two in Ireland and two in France.

Manulife led with eight funds, seven of them equity products, followed by iShares with five ETFs, UBAM with three funds, and HSBC with two funds approved. The list was completed with Axa, Nordea and WisdomTree each with one registered product.

The regulator also removed the following funds from its approved list for failing to meet its inclusion criteria:

Lazard Thematic Global Fund (concentrated ownership); Legg Mason QS MV European Equity Growth and Income (fell below USD 100 million in AUM); Pioneer Core European Equity (merged into other strategy)

The CCR also opened up a new avenue of potential revenue for the AFPs direct investment teams after authorizing stocks that are issued or traded on the Taiwan Stock Exchange.

To see the full list, download the report here: CCR Monthly Approval Report – March 2017